These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 9345104)

  • 1. Familial nontoxic multinodular thyroid goiter locus maps to chromosome 14q but does not account for familial nonmedullary thyroid cancer.
    Bignell GR; Canzian F; Shayeghi M; Stark M; Shugart YY; Biggs P; Mangion J; Hamoudi R; Rosenblatt J; Buu P; Sun S; Stoffer SS; Goldgar DE; Romeo G; Houlston RS; Narod SA; Stratton MR; Foulkes WD
    Am J Hum Genet; 1997 Nov; 61(5):1123-30. PubMed ID: 9345104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic heterogeneity in familial nonmedullary thyroid carcinoma: exclusion of linkage to RET, MNG1, and TCO in 56 families. NMTC Consortium.
    Lesueur F; Stark M; Tocco T; Ayadi H; Delisle MJ; Goldgar DE; Schlumberger M; Romeo G; Canzian F
    J Clin Endocrinol Metab; 1999 Jun; 84(6):2157-62. PubMed ID: 10372725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linkage of familial euthyroid goiter to the multinodular goiter-1 locus and exclusion of the candidate genes thyroglobulin, thyroperoxidase, and Na+/I- symporter.
    Neumann S; Willgerodt H; Ackermann F; Reske A; Jung M; Reis A; Paschke R
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3750-6. PubMed ID: 10523025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comprehensive analysis of MNG1, TCO1, fPTC, PTEN, TSHR, and TRKA in familial nonmedullary thyroid cancer: confirmation of linkage to TCO1.
    Bevan S; Pal T; Greenberg CR; Green H; Wixey J; Bignell G; Narod SA; Foulkes WD; Stratton MR; Houlston RS
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3701-4. PubMed ID: 11502798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of a susceptibility gene for familial nonmedullary thyroid carcinoma to chromosome 2q21.
    McKay JD; Lesueur F; Jonard L; Pastore A; Williamson J; Hoffman L; Burgess J; Duffield A; Papotti M; Stark M; Sobol H; Maes B; Murat A; Kääriäinen H; Bertholon-Grégoire M; Zini M; Rossing MA; Toubert ME; Bonichon F; Cavarec M; Bernard AM; Boneu A; Leprat F; Haas O; Lasset C; Schlumberger M; Canzian F; Goldgar DE; Romeo G
    Am J Hum Genet; 2001 Aug; 69(2):440-6. PubMed ID: 11438887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linkage analysis of candidate genes in autoimmune thyroid disease. III. Detailed analysis of chromosome 14 localizes Graves' disease-1 (GD-1) close to multinodular goiter-1 (MNG-1). International Consortium for the Genetics of Autoimmune Thyroid Disease.
    Tomer Y; Barbesino G; Greenberg DA; Concepcion E; Davies TF
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4321-7. PubMed ID: 9851771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2.
    Canzian F; Amati P; Harach HR; Kraimps JL; Lesueur F; Barbier J; Levillain P; Romeo G; Bonneau D
    Am J Hum Genet; 1998 Dec; 63(6):1743-8. PubMed ID: 9837827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping a dominant form of multinodular goiter to chromosome Xp22.
    Capon F; Tacconelli A; Giardina E; Sciacchitano S; Bruno R; Tassi V; Trischitta V; Filetti S; Dallapiccola B; Novelli G
    Am J Hum Genet; 2000 Oct; 67(4):1004-7. PubMed ID: 10986044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Greek family with a follicular variant of familial papillary thyroid carcinoma: TCO, MNG1, fPTC/PRN, and NMTC1 excluded as susceptibility loci.
    Tsilchorozidou T; Vafiadou E; Yovos JG; Romeo G; McKay J; Lesueur F; Bonora E
    Thyroid; 2005 Dec; 15(12):1349-54. PubMed ID: 16405407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping of a gene predisposing to familial thyroid tumors with cell oxyphilia to chromosome 19 and exclusion of JUN B as a candidate gene.
    Kraimps JL; Canzian F; Jost C; Menet E; Amati P; Levillian P; Harach R; Lesueur F; Barbier J; Romeo G; Bonneau D
    Surgery; 1999 Dec; 126(6):1188-94. PubMed ID: 10598206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping a new familial thyroid epithelial neoplasia susceptibility locus to chromosome 8p23.1-p22 by high-density single-nucleotide polymorphism genome-wide linkage analysis.
    Cavaco BM; Batista PF; Sobrinho LG; Leite V
    J Clin Endocrinol Metab; 2008 Nov; 93(11):4426-30. PubMed ID: 18765515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new locus for a dominant form of multinodular goiter on 3q26.1-q26.3.
    Takahashi T; Nozaki J; Komatsu M; Wada Y; Utsunomiya M; Inoue K; Takada G; Koizumi A
    Biochem Biophys Res Commun; 2001 Jun; 284(3):650-4. PubMed ID: 11396950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide linkage analysis reveals evidence for four new susceptibility loci for familial euthyroid goiter.
    Bayer Y; Neumann S; Meyer B; Rüschendorf F; Reske A; Brix T; Hegedüs L; Langer P; Nürnberg P; Paschke R
    J Clin Endocrinol Metab; 2004 Aug; 89(8):4044-52. PubMed ID: 15292347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further indications for genetic heterogeneity of euthyroid familial goiter.
    Neumann S; Bayer Y; Reske A; Tajtáková M; Langer P; Paschke R
    J Mol Med (Berl); 2003 Nov; 81(11):736-45. PubMed ID: 14564411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. At least three genes account for familial papillary thyroid carcinoma: TCO and MNG1 excluded as susceptibility loci from a large Tasmanian family.
    McKay JD; Williamson J; Lesueur F; Stark M; Duffield A; Canzian F; Romeo G; Hoffman L
    Eur J Endocrinol; 1999 Aug; 141(2):122-5. PubMed ID: 10427154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2B map to the same region of chromosome 10 as multiple endocrine neoplasia type 2A.
    Lairmore TC; Howe JR; Korte JA; Dilley WG; Aine L; Aine E; Wells SA; Donis-Keller H
    Genomics; 1991 Jan; 9(1):181-92. PubMed ID: 1672289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Progress in the molecular genetic research of multinodular goiter].
    Zhang R; Du L; Peng Z; Chu J; Liu X; Tao S; Luo Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Oct; 17(5):359-61. PubMed ID: 11024220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperfunctioning thyroid nodules in toxic multinodular goiter share activating thyrotropin receptor mutations with solitary toxic adenoma.
    Tonacchera M; Chiovato L; Pinchera A; Agretti P; Fiore E; Cetani F; Rocchi R; Viacava P; Miccoli P; Vitti P
    J Clin Endocrinol Metab; 1998 Feb; 83(2):492-8. PubMed ID: 9467563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activating thyrotropin receptor mutations are present in nonadenomatous hyperfunctioning nodules of toxic or autonomous multinodular goiter.
    Tonacchera M; Agretti P; Chiovato L; Rosellini V; Ceccarini G; Perri A; Viacava P; Naccarato AG; Miccoli P; Pinchera A; Vitti P
    J Clin Endocrinol Metab; 2000 Jun; 85(6):2270-4. PubMed ID: 10852462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial non-medullary thyroid carcinoma (FNMTC): analysis of fPTC/PRN, NMTC1, MNG1 and TCO susceptibility loci and identification of somatic BRAF and RAS mutations.
    Cavaco BM; Batista PF; Martins C; Banito A; do Rosário F; Limbert E; Sobrinho LG; Leite V
    Endocr Relat Cancer; 2008 Mar; 15(1):207-15. PubMed ID: 18310288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.